SCVJX | VISVX | SCVJX / VISVX | |
Total Expense Ratio | 0.75 | 0.19 | 395% |
Annual Report Gross Expense Ratio | 0.88 | 0.19 | 463% |
Fund Existence | 9 years | 27 years | - |
Gain YTD | -0.108 | 4.208 | -3% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 575M | 59.1B | 1% |
Annual Yield % from dividends | 1.47 | 1.88 | 78% |
Returns for 1 year | -9.58 | 0.97 | -987% |
Returns for 3 years | 17.48 | 36.12 | 48% |
Returns for 5 years | 56.80 | 75.74 | 75% |
Returns for 10 years | N/A | 108.98 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FRI | 28.17 | 0.25 | +0.88% |
First Trust S&P REIT ETF | |||
LVHD | 41.20 | 0.29 | +0.72% |
Franklin U.S. Low Volatility Hi Div ETF | |||
BDCZ | 16.16 | 0.10 | +0.64% |
UBS ETRACS Wells Fargo® Busn Dev Co ETN | |||
ZSEP | 26.52 | -0.02 | -0.08% |
Innovator Equity Defined Prot ETF-1YrSep | |||
XBI | 107.80 | -0.11 | -0.10% |
SPDR® S&P Biotech ETF |